Abstract

Animal models of rheumatoid arthritis (RA) provide useful systems for the characterization of the immunopathogenic mechanisms of chronic inflammatory synovitis. Although at least eight models have been described, the adjuvant arthritis, streptococcal cell wall-induced arthritis, and collagen-induced arthritis models have provided the most useful insights. Each of these three models has contributed clues to our understanding of RA and have yielded promising new approaches to treatment. These include combination pharmacotherapy, antigen-specific therapy, cell-specific therapy, and monoclonal antibody therapy. All of these immunotherapeutic interventions have been shown to be beneficial in one or more animal systems. This suggests that future therapies for RA and other human autoimmune diseases may be more immunoselective and, potentially, less toxic.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.